2709 results found
2021 ANSTO Eureka Prize for Innovative Use of Technology
The Human Frontier Science Program (HFSP) was established in 1990 to promote international collaboration in basic research focused on the elucidation of the sophisticated and complex mechanisms of living organisms. Since then, 1180 research grants have been awarded to more than 7500 researchers representing 71 nationalities, including Australia. HFSP Secretary-General Professor Pavel Kabat introduces the program and three prominent researchers tell us how their HFSP grants advanced their research.
Over the last 10 years NHMRC has invested more than $191 million in research on malaria1
An estimated 1 in 10 Australian adults (10%) - about 1.7 million people in 2011 - 12 - had biomedical signs of chronic kidney disease1
Glaucoma is a leading cause of irreversible blindness worldwide, with an estimated 80 million people predicted to be affected by 2020.
Hepatitis B is an infectious disease that causes the liver to become inflamed and contributes to increasing rates of liver cancer in Australia and globally.
Professor Louisa Jorm is the Foundation Director of the Centre for Big Data Research in Health at UNSW Sydney.
Associate Professor Antony Cooper from the Garvan Institute of Medical Research is a cell and molecular biologist / geneticist with strong interests in elucidating how cellular dysfunction results in human diseases, with a specific interest in neurodegenerative disease such as Parkinson’s Disease. His research on neurodegenerative diseases focuses on understanding the basis of Parkinson’s Disease. Watch his story in the video below.
Sapphire is NHMRC's solution for supporting end-to-end management of all Medical Research Endowment Account (MREA) grant opportunities (GOs) as well as Medical Research Future Fund (MRFF) GOs administered by NHMRC on behalf of the Department of Health and Aged Care.
Developing better understanding of effective therapeutic practices with Aboriginal clients, in Aboriginal community settings, and with Aboriginal practitioners, across the spectrum of mental health and social and emotional wellbeing outcomes is the goal of Dr Graham Gee.
The eighth meeting of the National Health and Medical Research Council’s (NHMRC) Dietary Guidelines Expert Committee (Expert Committee) was held in April via videoconference.
This document clarifies the responsibilities of those involved in clinical trials to monitor and report adverse events and other safety issues. Supplementary guidance on other clinical trial safety monitoring and reporting issues is also available*.